The stock of LifeStance Health Group Inc (LFST) has seen a -1.02% decrease in the past week, with a -2.15% drop in the past month, and a 35.32% flourish in the past quarter. The volatility ratio for the week is 2.98%, and the volatility levels for the past 30 days are at 3.15% for LFST. The simple moving average for the past 20 days is -0.76% for LFST’s stock, with a 7.98% simple moving average for the past 200 days.
Is It Worth Investing in LifeStance Health Group Inc (NASDAQ: LFST) Right Now?
LFST has 36-month beta value of 1.24. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 4 as “hold,” and 1 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for LFST is 110.97M, and currently, short sellers hold a 10.79% ratio of that float. The average trading volume of LFST on October 09, 2024 was 1.64M shares.
LFST) stock’s latest price update
The stock price of LifeStance Health Group Inc (NASDAQ: LFST) has jumped by 2.25 compared to previous close of 6.67. Despite this, the company has seen a fall of -1.02% in its stock price over the last five trading days. prnewswire.com reported 2024-10-08 that Election stress is contributing to an increase in anxiety and strained relationships, reinforcing the importance of accessible mental healthcare SCOTTSDALE, Ariz., Oct. 8, 2024 /PRNewswire/ — A LifeStance Health survey released today reveals how widespread election-related anxiety is impacting Americans’ mental health, straining their personal relationships and prompting many to limit social media exposure.
Analysts’ Opinion of LFST
Many brokerage firms have already submitted their reports for LFST stocks, with Barclays repeating the rating for LFST by listing it as a “Underweight.” The predicted price for LFST in the upcoming period, according to Barclays is $7 based on the research report published on January 03, 2024 of the current year 2024.
TD Cowen, on the other hand, stated in their research note that they expect to see LFST reach a price target of $9, previously predicting the price at $8. The rating they have provided for LFST stocks is “Market Perform” according to the report published on May 15th, 2023.
Morgan Stanley gave a rating of “Overweight” to LFST, setting the target price at $8 in the report published on January 06th of the previous year.
LFST Trading at 7.14% from the 50-Day Moving Average
After a stumble in the market that brought LFST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.87% of loss for the given period.
Volatility was left at 3.15%, however, over the last 30 days, the volatility rate increased by 2.98%, as shares surge +1.19% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +23.33% upper at present.
During the last 5 trading sessions, LFST fell by -1.02%, which changed the moving average for the period of 200-days by -6.70% in comparison to the 20-day moving average, which settled at $6.87. In addition, LifeStance Health Group Inc saw -12.90% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LFST starting from KHAN IRREVOCABLE TRUST LLC, who proposed sale 87,830 shares at the price of $6.94 back on Sep 13 ’24. After this action, KHAN IRREVOCABLE TRUST LLC now owns shares of LifeStance Health Group Inc, valued at $609,540 using the latest closing price.
Varanakis Ann, the Chief People Officer of LifeStance Health Group Inc, sale 5,269 shares at $6.28 during a trade that took place back on Aug 23 ’24, which means that Varanakis Ann is holding 263,007 shares at $33,089 based on the most recent closing price.
Stock Fundamentals for LFST
Current profitability levels for the company are sitting at:
- -0.12 for the present operating margin
- 0.25 for the gross margin
The net margin for LifeStance Health Group Inc stands at -0.13. The total capital return value is set at -0.07. Equity return is now at value -10.32, with -7.04 for asset returns.
Based on LifeStance Health Group Inc (LFST), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at 0.04. The debt to equity ratio resting at 0.23. The interest coverage ratio of the stock is -6.07.
Currently, EBITDA for the company is -106.91 million with net debt to EBITDA at -7.48. When we switch over and look at the enterprise to sales, we see a ratio of 2.61. The receivables turnover for the company is 6.91for trailing twelve months and the total asset turnover is 0.55. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.22.
Conclusion
To put it simply, LifeStance Health Group Inc (LFST) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
